Related references
Note: Only part of the references are listed.Muscle involvement in SARS-CoV-2 infection
L. Pitscheider et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic
Gianluca Costamagna et al.
JOURNAL OF NEUROLOGY (2021)
COVID-19 in children with neuromuscular disorders
Daniel Natera-de Benito et al.
JOURNAL OF NEUROLOGY (2021)
Efficacy of vitamin C in patients with sepsis: An updated meta-analysis
Xue-biao Wei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Adapted physical activity and therapeutic exercise in late-onset Pompe disease (LOPD): a two-step rehabilitative approach
Giovanni Iolascon et al.
NEUROLOGICAL SCIENCES (2020)
Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review
Shelagh M. Szabo et al.
QUALITY OF LIFE RESEARCH (2020)
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
Saiju Jacob et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Guillain-Barre syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature
Erika Scheidl et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2020)
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Ling Mao et al.
JAMA NEUROLOGY (2020)
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic
Aravindhan Veerapandiyan et al.
MUSCLE & NERVE (2020)
Spinal muscular atrophy care in the COVID-19 pandemic era
Aravindhan Veerapandiyan et al.
MUSCLE & NERVE (2020)
COVID-19 in patients with myasthenia gravis
Pria Anand et al.
MUSCLE & NERVE (2020)
COVID-19 and neuromuscular disorders
Amanda C. Guidon et al.
NEUROLOGY (2020)
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China
J. Zhang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
COVID-19 and pulmonary rehabilitation: preparing for phase three
Massimiliano Polastri et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
COVID-19: a major cause of cachexia and sarcopenia?
John E. Morley et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Role of vitamin D in preventing of COVID-19 infection, progression and severity
Nurshad Ali
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Central nervous system manifestations of COVID-19: A systematic review
Ali A. Asadi-Pooya et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
John R. Giudicessi et al.
MAYO CLINIC PROCEEDINGS (2020)
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network
G. Sole et al.
REVUE NEUROLOGIQUE (2020)
Rehabilitation of patients post-COVID-19 infection: a literature review
A. Demeco et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Neuromuscular presentations in patients with COVID-19
Vimal Kumar Paliwal et al.
NEUROLOGICAL SCIENCES (2020)
Rhabdomyolysis as Potential Late Complication Associated with COVID-19
Min Jin et al.
EMERGING INFECTIOUS DISEASES (2020)
Validity and Reliability of the 32-Item Motor Function Measure in 2-to 5-Year-Olds with Neuromuscular Disorders and 2-to 25-Year-Olds with Spinal Muscular Atrophy
Dylan Trundell et al.
NEUROLOGY AND THERAPY (2020)
Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease
Kulachanya Suwanwongse et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Peripheral Blood and Cerebrospina Fluid Cytokine Levels in Guillain Barre Syndrome: A Systematic Review and Meta-Analysis
Ting Sun et al.
FRONTIERS IN NEUROSCIENCE (2019)
Neuromuscular Diseases and Bone
Giovanni Iolascon et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Two-minute versus 6-minute walk distances during 6-minute walk test in neuromuscular disease: Is the 2-minute walk test an effective alternative to a 6-minute walk test?
J. W. Witherspoon et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2019)
Combined noninvasive ventilation and mechanical insufflator-exsufflator for acute respiratory failure in patients with neuromuscular disease: effectiveness and outcome predictors
Tai-Heng Chen et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Respiratory muscle training in children and adults with neuromuscular disease
Ivanizia S. Silva et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management (vol 17, pg 251, 2018)
J. F. Zimmermann et al.
LANCET NEUROLOGY (2018)
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
Eugenio Mercuri et al.
NEUROMUSCULAR DISORDERS (2018)
36-Months follow-up assessment after cessation and resuming of enzyme replacement therapy in late onset Pompe disease: data from the Swiss Pompe Registry
Olivier Scheidegger et al.
JOURNAL OF NEUROLOGY (2018)
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
David J. Birnkrant et al.
LANCET NEUROLOGY (2018)
Neurological Complications during Treatment of Middle East Respiratory Syndrome
Jee-Eun Kim et al.
JOURNAL OF CLINICAL NEUROLOGY (2017)
Update on the respiratory management of patients with chronic neuromuscular disease
P. Priou et al.
REVUE DE PNEUMOLOGIE CLINIQUE (2017)
Review of Critical Illness Myopathy and Neuropathy
Starane Shepherd et al.
NEUROHOSPITALIST (2017)
Respiratory involvement in neuromuscular disorders
Matthias Boentert et al.
CURRENT OPINION IN NEUROLOGY (2017)
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Richard S. Finkel et al.
LANCET (2016)
Development of a Barthel Index based on dyspnea for patients with respiratory diseases
Michele Vitacca et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Physiology of respiratory disturbances in muscular dystrophies
Antonella Lo Mauro et al.
BREATHE (2016)
Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases
Md. Abdul Alim Al-Bari
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Respiratory involvement in neuromuscular disease
Stephen C. Bourke
CLINICAL MEDICINE (2014)
Respiratory Management of Spinal Muscular Atrophy Type 2
Maurade C. Gormley
JOURNAL OF NEUROSCIENCE NURSING (2014)
Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale
Ulla Werlauff et al.
QUALITY OF LIFE RESEARCH (2014)
Share Paper
